Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
3
|
| pubmed:dateCreated |
1993-7-16
|
| pubmed:abstractText |
The role of imaging in the staging of malignant melanoma is reviewed. Computed tomography (CT) and magnetic resonance (MR) are useful for detecting liver, lung, and central nervous system (CNS) metastases in asymptomatic patients at high risk and in symptomatic patients. Plain films, bone scan, and gastrointestinal (GI) studies are useful in patients with skeletal or GI complaints. Additionally, imaging studies have a primary role for ascertaining the response, if any, to treatment.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:status |
MEDLINE
|
| pubmed:issn |
8756-0437
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
9
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
232-8
|
| pubmed:dateRevised |
2005-11-16
|
| pubmed:meshHeading | |
| pubmed:articleTitle |
Radiologic imaging in malignant melanoma: a review.
|
| pubmed:affiliation |
Department of Radiology, University of South Florida, Tampa.
|
| pubmed:publicationType |
Journal Article,
Review
|